דיספטיל פורטה קפליות
rekah pharmaceutical industry ltd, israel - sulphamethoxazole; trimethoprim - קפליות - trimethoprim 160 mg; sulphamethoxazole 800 mg - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - antibacterial treatment in infections due to susceptible microorganisms in urinary, respiratory and gastro-intestinal tract or genital system infections.
דיפרלין 0.1 מג
medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תמיסה להזרקה - triptorelin as acetate 0.1 mg/vial - triptorelin - triptorelin - female infertility: management of ovarian stimulation in association with the gonadotrophins (hmg, fsh, hcg) in view of in vitro fertilisation and embrio transfer (i.v.f.e.t.) and other assisted conception techniques.
קזודקס 150 מג
astra zeneca (israel) ltd - bicalutamide - טבליה - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) casodex 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
ביקאלוטמיד טבע 150 מג
teva israel ltd - bicalutamide - טבליה - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
ביקמיד 150 מ"ג
taro international ltd - bicalutamide 150 mg - film coated tablets - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) bicamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
ביקאלוטמיד אינובמד 150 מג
inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable
בנליסטה תוך ורידי 120 מג
glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 120 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.
בנליסטה תוך ורידי 400 מג
glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 400 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.
מלרון טבליות לילדים
glaxo smith kline (israel) ltd - atovaquone; proguanil hydrochloride - טבליות מצופות פילם - atovaquone 62.5 mg; proguanil hydrochloride 25 mg - proguanil, combinations - proguanil, combinations - prevention of malaria: for the prophylaxis of p.falciparum malaria, including in areas where chloroquine resistance has been reported. treatment of malaria: for the treatment of acute, uncomplicated p.flaciparum malaria. malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and modiaquine may have unacceptable failure rates, presumably due to drug resistance.malarone is recommended for pediatric patients who weigh over 11 kg.
מלרון טבליות למבוגרים
glaxo smith kline (israel) ltd - atovaquone; proguanil hydrochloride - טבליות מצופות פילם - atovaquone 250 mg; proguanil hydrochloride 100 mg - proguanil, combinations - proguanil, combinations - prevention of malaria: for the prophylaxis of p.falciparum malaria, including in areas where chloroquine resistance has been reported. treatment of malaria: for the treatment of acute, uncomplicated p.flaciparum malaria. malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and modiaquine may have unacceptable failure rates, presumably due to drug resistance.